📋 Tender Overview
Scope : To Set up a Injectables Manufacturing Plant near Hosur, Tamil Nadu.
Maiva Pharma, a Bengaluru-based injectables manufacturer, has secured Rs 1,000 crore in a mix of primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund-IV, led by InvAscent, to set up a new manufacturing plant near Hosur, Tamil Nadu.
The fund has acquired a controlling stake with the capital infusion, making it Maiva Pharma’s first private equity fundraise. Avendus acted as the exclusive financial advisor to Maiva and its shareholders on this transaction.
The company also aims to deploy the proceeds to enhance its capabilities in sterile dosage forms including pre-filled syringes, bags, oncology and hormonal injectables.
This fundraise will be used to add more vial, lyophilization, and suspension capacity and introduce new manufacturing capabilities such as prefilled syringes, cartridges and bags
